SCHEMBL24254575

SCHEMBL24254575

Cc1ccc(SN(C)C)cc1NC(=O)Cc1ccc(Cl)c(Cl)c1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.53
LMNA P02545 3/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
ALDH1A1 P00352 3/20 0.53
HTT P42858 2/20 0.53
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
TRPV1 Q8NER1 1/20 0.45
KCNQ2 O43526 1/20 0.45
KDM4E B2RXH2 1/20 0.44
CLK1 P49759 1/20 0.44
POLB P06746 1/20 0.44
GAA P10253 1/20 0.43
MCOLN3 Q8TDD5 1/20 0.43
LOXL2 Q9Y4K0 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24254515 0.87 MAPT (0.48) MAPTLMNASMN1; SMN2ALDH1A1HTT
SCHEMBL24254545 0.84 SELL (0.45) MAPTLMNASMN1; SMN2HTTMEN1
SCHEMBL24254523 0.83 HPGD (0.59) MAPTLMNASMN1; SMN2ALDH1A1HTT
SCHEMBL24254507 0.80 MEN1 (0.48) MAPTLMNASMN1; SMN2ALDH1A1HTT
SCHEMBL24254547 0.80 MEN1 (0.58) MAPTLMNASMN1; SMN2ALDH1A1HTT
SCHEMBL24254578 0.80 L3MBTL1 (0.57) MAPTLMNAALDH1A1HTTMEN1
SCHEMBL24254550 0.79 HPGD (0.46) MAPTLMNASMN1; SMN2ALDH1A1HTT
SCHEMBL24254623 0.79 KCNQ2 (0.53) MAPTLMNASMN1; SMN2ALDH1A1HTT
SCHEMBL24254502 0.78 ALDH1A1 (0.66) MAPTLMNASMN1; SMN2ALDH1A1HTT
SCHEMBL24254539 0.78 MAPT (0.53) MAPTLMNASMN1; SMN2ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022035804-A1 SUBSTITUTED 3-AMINO-4-METHYLBENZENESULFONAMIDES AS SMALL MOLECULE INHIBITORS OF UBIQUITIN-SPECIFIC PROTEASE 28 DANA-FARBER CANCER INSTITUTE, INC. (US) 2022-02-17 WO disclosed